Nicole Lemerond
CIK: 0001941712
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 23, 2026MNOV
MEDICINOVA INC
Award(A)DirectStock Option (Right to Buy)
44.5K shares- - Jun 17, 2026GOVX
GeoVax Labs, Inc.
Award(A)DirectStock Option
6K shares- - Dec 19, 2025INM
InMed Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
1.8K shares- - Jun 17, 2025MNOV
MEDICINOVA INC
Award(A)DirectStock Option (Right to Buy)
20K shares- - Jun 5, 2025GOVX
GeoVax Labs, Inc.
Award(A)DirectStock Option
10K shares- - Feb 12, 2025MNOV
MEDICINOVA INC
Award(A)DirectStock Option (Right to Buy)
24.5K shares- - Dec 20, 2024INM
InMed Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
550 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 |  MNOV MEDICINOVA INC | Award(A) Stock Option (Right to Buy) | 44,500 | - | - | Direct |
| Jun 17, 2026 |  GOVX GeoVax Labs, Inc. | Award(A) Stock Option | 6,000 | - | - | Direct |
| Dec 19, 2025 |  INM InMed Pharmaceuticals Inc. | Award(A) Employee Stock Option (Right to Buy) | 1,750 | - | - | Direct |
| Jun 17, 2025 | MNOV MEDICINOVA INC | Award(A) Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Jun 5, 2025 | GOVX GeoVax Labs, Inc. | Award(A) Stock Option | 10,000 | - | - | Direct |
| Feb 12, 2025 | MNOV MEDICINOVA INC | Award(A) Stock Option (Right to Buy) | 24,500 | - | - | Direct |
| Dec 20, 2024 | INM InMed Pharmaceuticals Inc. | Award(A) Employee Stock Option (Right to Buy) | 550 | - | - | Direct |
1-7 of 7 transactions
About Lemerond Nicole
Lemerond Nicole (SEC CIK 0001941712) files insider reports with the SEC as Director of MEDICINOVA INC (MNOV), Director of GeoVax Labs, Inc. (GOVX) and Director of InMed Pharmaceuticals Inc. (INM).
Signal8 holds 7 ownership filings by Lemerond Nicole, all Form 4s, filed between Dec 23, 2024 and Jun 25, 2026. Those filings report 7 transactions, from Dec 20, 2024 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lemerond Nicole's filings is in SMYRNA, GA.
Recent filings by Lemerond Nicole
- Jun 23, 2026: Grant or award of MNOV derivative securities (Form 4, code A).
- Jun 17, 2026: Grant or award of GOVX derivative securities (Form 4, code A).
- Dec 19, 2025: Grant or award of INM derivative securities (Form 4, code A).
- Jun 17, 2025: Grant or award of MNOV derivative securities (Form 4, code A).
- Jun 5, 2025: Grant or award of GOVX derivative securities (Form 4, code A).
Other insiders filing for MEDICINOVA INC (MNOV)
- 3D Investment Partners Pte. Ltd., Officer
- Nagao Hideki, Director
- BEAVER CAROLYN, Director
- Matsuda Kazuko, Chief Medical Officer
- IWAKI YUICHI, President and CEO